Fig. 3From: Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study)The distribution of circadian blood pressure patterns at baseline and after 24 weeks of add-on dapagliflozin treatment (week 24)Back to article page